app_localeMedicare honlap
Nyelvválasztás megjegyzése.
1 év
first-party
Faecal M2-PK (enzymatic intestinal tumour screening) and faecal blood (human haemoglobin)
Faecal M2-PK (enzymatic bowel tumour screening) is a new screening test for colorectal cancer that targets a tumour marker enzyme. Most tumours in the human body produce large amounts of the pyruvate kinase (PK) dimeric M2 isoenzyme. This tumour M2-PK is derived from tumour cells and can be quantified in body fluids.
A positive result may indicate gastrointestinal gland cancer (gastrointestinal adenoma), rectal malignancy (colorectal carcinoma), or other gastrointestinal malignancy (gastrointestinal carcinoma).
In case of a positive finding, further examinations and colonoscopy are recommended. If a too diluted stool is tested, the test may give a false low value. The test requires a special sampling device, which can be requested at Medicare Clinics.
How do I prepare for the test?
It is important to note that diarrheal stools are not suitable for testing and should not take place during menstruation! You can request the special sampling container at the reception of our Clinics.
When is the result expected?
7 working days after the examination.
Informational content only The textual content published on this page is for general information purposes only and does not constitute medical advice, a diagnosis, or a treatment recommendation. Proper assessment, examination, and therapeutic decisions always require a personal medical consultation and, where appropriate, further specialist opinion. Medicare Egészségközpont Zrt. makes every reasonable effort to keep the content up to date; however, it accepts no liability for the completeness or accuracy of the information published or for consequences arising from decisions based on it.